Fig. 1: Treatment Discontinuation Rate.
A, B Proportion of patients who discontinued CDK 4/6 treatment before the completion of 12 months, stratified by prior duration of ET < 2 years vs ≥ 2 years (a), stage I/II vs III (b).
Fig. 1: Treatment Discontinuation Rate. | npj Breast Cancer
